We raised just over £63,000 at our first Gala in Scotland
Date
News
Date
GDNF clinical trial results in 2019 revealed signs that GDNF may make it possible to repair the cells damaged in people with Parkinson's. We take a look at where we are 1 year later.
Date
A promising molecule, called BT13, has offered hope for a new treatment that could stop or slow Parkinson's, something no treatment can currently do.
Date
New research suggests that a bacteria which boosts digestive health can slow – and even reverse – the build-up of a protein associated with Parkinson's.
Date
In our survey of more than 2,000 people, more than a quarter (26%) reported they were misdiagnosed with a different condition before receiving the correct Parkinson's diagnosis.
Date
we announce the winners of our first volunteer awards
Date
2019 was another exciting year of progress. Here are 8 of the highlights, and 8 ways you can still get involved.
Date
Researchers, funded by Parkinson's UK, have produced positive results in mice for a gene therapy treatment that directly targets the production of the alpha-synuclein protein.
Date
Alongside Alzheimer's Research UK, we're funding new research that will investigate whether boosting the brain's self-cleaning system could be the key to new treatments.
Date
The report, Get It On Time, highlights systematic failures in Scotland's hospitals that mean that people with Parkinson's don't receive their vital medication at their prescribed times.
Date
The Parkinson's community in Scotland, and beyond, has lost one of its giants with the passing of Professor Ken Bowler. Ken revolutionised the relationship between researchers and people living with Parkinson's.